HKU Scholars Hub: Browsing DSpace

Browsing by Author Macfarlane, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 4 to 7 of 7 < previous

	Title	Author(s)	Issue Date	Views
	Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response Proceeding/Conference:Hepatology	Yuen, RMF Elkhashab, M Chen, CY Chen, YF Coffin, CS Fung, SK Greenbloom, S Jang, JW Jeng, WJ Kim, DJ Kim, YJ Kim, W Lee, KS Lim, YS Liu, CJ Ramji, A Iyer, R Macfarlane, C Jackson, K Locarnini, S Afdhal, NH Chan, HLY ACHIEVE STUDY Investigators,	2018	28
	Inarigivir: a novel RIG-I agonist for chronic hepatitis B Proceeding/Conference:Hepatology International	Macfarlane, C Locarnini, S Jackson, K Walsh, R Edwards, R Hammond, R Coffin, C Elkhashab, M Greenbloom, S Ramji, A Chan, HLY Afdhal, W Kim, N Afdhal, N Yuen, RMF Wong, DKH Lyer, R	2018	77
	Novel anti-viral activity of SB 9200, a RIGI agonist; results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology	Locarnini, S Wong, DKH Jackson, K Walsh, R Edwards, R Hammond, R Macfarlane, C Iyer, RP Afdhal, NH Yuen, RMF	2017	32
	SB 9200 an oral selective immunomodulator is safe and efficacious in treatment-naive, non-cirrhotic HBV patients: Results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology	Yuen, RMF Coffin, CS Elkhashab, M Greenbloom, S Ramji, A Chan, HLY Iyer, RP Locarnini, S Macfarlane, C Afdhal, NH Kim, W	2017	44

Showing results 4 to 7 of 7 < previous